Under the IMI brand in the Life Science sector — supported by our two product brands, IMI FAS and IMI Adaptas — we address complex fluid and detection challenges to enable earlier disease diagnosis and deliver highly tailored, patient-focused critical care.
Our high-precision components — including valves, syringe pumps, and detection technologies — are designed to increase throughput, improve analytical sensitivity, and maximise instrument uptime. This ensures faster, more reliable results from the world’s most advanced analytical and diagnostic platforms, supporting better decision-making in labs, clinics, and at the point of care.
We also support a wide range of critical care systems, helping ventilators, anaesthesia machines, and other frontline technologies operate safely and efficiently. All our solutions are developed in close collaboration with OEMs to meet the highest standards of reliability, accuracy, and performance.
With decades of deep application expertise, IMI is a trusted partner to leading OEMs in analytical instrumentation, biosciences, and critical care — delivering precision technologies that improve outcomes for patients, researchers, and clinicians worldwide.
